Arocell Ab Stock Cash Flow From Operations
| AROC Stock | SEK 0.40 0.03 6.98% |
AroCell AB fundamentals help investors to digest information that contributes to AroCell AB's financial success or failures. It also enables traders to predict the movement of AroCell Stock. The fundamental analysis module provides a way to measure AroCell AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AroCell AB stock.
AroCell |
AroCell AB Company Cash Flow From Operations Analysis
AroCell AB's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current AroCell AB Cash Flow From Operations | (28.21 M) |
Most of AroCell AB's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AroCell AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, AroCell AB has (28.21 Million) in Cash Flow From Operations. This is 105.35% lower than that of the Life Sciences Tools & Services sector and 100.57% lower than that of the Health Care industry. The cash flow from operations for all Sweden stocks is 102.9% higher than that of the company.
AroCell Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AroCell AB's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AroCell AB could also be used in its relative valuation, which is a method of valuing AroCell AB by comparing valuation metrics of similar companies.AroCell AB is currently under evaluation in cash flow from operations category among its peers.
AroCell Fundamentals
| Return On Equity | -0.26 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (2.04) % | |||
| Operating Margin | (2.07) % | |||
| Current Valuation | 63.02 M | |||
| Shares Outstanding | 230.36 M | |||
| Shares Owned By Insiders | 41.61 % | |||
| Price To Earning | (11.21) X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 4.05 X | |||
| Revenue | 12 M | |||
| Gross Profit | (5.04 M) | |||
| EBITDA | (45.23 M) | |||
| Net Income | (50.02 M) | |||
| Cash And Equivalents | 21.43 M | |||
| Cash Per Share | 0.52 X | |||
| Current Ratio | 10.33 X | |||
| Book Value Per Share | 1.04 X | |||
| Cash Flow From Operations | (28.21 M) | |||
| Earnings Per Share | (0.50) X | |||
| Target Price | 2.3 | |||
| Number Of Employees | 20 | |||
| Beta | 1.38 | |||
| Market Capitalization | 152.77 M | |||
| Total Asset | 227.41 M | |||
| Retained Earnings | (5 M) | |||
| Working Capital | 41 M | |||
| Current Asset | 44 M | |||
| Current Liabilities | 3 M | |||
| Net Asset | 227.41 M |
About AroCell AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AroCell AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AroCell AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AroCell AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AroCell Stock Analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.